Kuros Biosciences AG Capital Reinvestment Ratio

Latest as of December 2025: 0.53x

Kuros Biosciences AG capital reinvestment ratio. Kuros Biosciences AG (KURN) has a Capital Reinvestment Ratio of 0.53x as of December 2025, meaning it reinvests 1% of its operating cash flow (CHF1.94 Million) in capital expenditures (CHF1.03 Million). See Kuros Biosciences AG free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.53x

Capex / Operating Cash Flow

Operating Cash Flow

CHF1.94 Million

CHF

Capital Expenditures

CHF1.03 Million

CHF

Data as of

Dec 2025

Most recent filing

Capital Reinvestment Ratio of Kuros Biosciences AG (2024–2024)

Capital reinvestment ratio of Kuros Biosciences AG from 2024 to 2024. This chart tracks Kuros Biosciences AG's Capital Reinvestment Ratio across 1 annual periods. See Kuros Biosciences AG leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Kuros Biosciences AG Capital Reinvestment Ratio by Year (2024–2024)

Kuros Biosciences AG capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see KURN cash flow metrics.

Year	Reinvestment Ratio	Operating CF (CHF)	Capital Expenditures	YoY Change
2024	0.35x	CHF3.14 Million	CHF1.11 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow